Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
This Notice of Funding Opportunity (NOFO) invites applications to develop and implement multi-site Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer's disease (AD) and other age-related dementias
using the Alzheimer's disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure.
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-010.html
Additional Information of Eligibility:Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession.
Full Opportunity Web Address:http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-010.htmlContact: Agency Email Description: See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Agency Email: Date Posted: 2024-07-01
Application Due Date: Archive Date: 2024-11-22
301 Moved Permanently
Moved Permanently
The document has moved here.